Skip to main content
. Author manuscript; available in PMC: 2022 Aug 22.
Published in final edited form as: Br J Clin Pharmacol. 2020 Jul 5;87(2):622–631. doi: 10.1111/bcp.14429

Figure 2. Forest plot of main, subgroup and sensitivity analyses: Adjusted odds ratio of ≥1g/dL haemoglobin reduction in ACEI/ARB initiators vs. CCB initiators.

Figure 2

ACEI/ARB, ACE inhibitor / angiotensin receptor blocker; CCB, calcium channel blocker; CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate.

a Adjusted for age, sex and pre-initiation haemoglobin, co-morbidities (hypertension, ischaemic heart disease, heart failure, diabetes, chronic hypoxic conditions, chronic kidney disease), medications (oral bone marrow suppressing drugs, drugs that can cause bleeding), calendar period and clustering at primary care practice level.

b Additionally adjusted for smoking status, alcohol intake and body mass index.